click below
click below
Normal Size Small Size show me how
Anti-HPTN/Anti-Angio
USMLE Step 1
Drug | MOA & ADRs |
---|---|
Diltiazem | MOA: Ca channel blocker used in all pts affecting the vasculature and the heart; ADRs: don't use in CHF, constipation, vertigo, headache, fatigue and hypoTN; *Note used when 1st line don't work* |
Nifedipine | MOA: Ca channel blocker used in all pts affects the vasculature; ADRs: don't use in CHF, constipation, vertigo, headache, fatigue and hypoTN; *Note used when 1st line don't work* |
Verapamil | MOA: Ca channel blocker used in all pts affecting both the heart and the vasculature; ADRs: don't use in CHF, constipation, vertigo, headache, fatigue and hypoTN; *Note used when 1st line don't work* |
Propranolol | MOA: Beta-blocker used in angina pectoris & post MI, also 1st line drug for HPTN, decrease beta-1 receptor +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Timolol | MOA: Beta-blocker used in angina pectoris & post MI, also 1st line drug for HPTN, decrease beta-1 receptor +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Atenolol | MOA: used in angina pectoris & post MI, 1st line drug for HPTN, decrease beta-1 receptor (more selective) +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Labetalol | MOA: used in angina pectoris & post MI, 1st line drug for HPTN, decrease beta-1 receptor (alpha - too) +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Metoprolol | MOA: Beta-blocker used in angina pectoris & post MI, also 1st line drug for HPTN, decrease beta-1 receptor +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Nadolol | MOA: Beta-blocker used in angina pectoris & post MI, also 1st line drug for HPTN, decrease beta-1 receptor +; ADRs: don't use in DM, asthma, COPD & peripheral vascular disease, causes fatigue, insomnia, impotence, decreased HDL & increased TGs, depression |
Thiazide | MOA: 1st line drug for HPTN, block Na in the DCT used for CHF & chronic renal failure; ADRs: dont use in DM & hyperlipidemia, causes hypokalemia, hypercalcemia & hyperuricemia |
Captopril | MOA: ACEI for all pts, anti-HPTN of choice for DM, reserved 4 pts whom diuretics or beta-blockers r unsuccessful, increase bradykinin; ADRs: dry cough, rash, fever, altered taste, hypoTN, hyperkalemia, angioedema & 1st dose syncope, don't use in pregnancy |
Lisinopril | MOA: ACEI used in all pts, anti-HPTN of choice for DM, reserved for pts for whom diuretics or beta-blockers are unsuccessful; ADRs: dry cough, rash, fever, altered taste, hypoTN, hyperkalemia, angioedema & 1st dose syncope, don't use in pregnancy |
Enalapril | MOA: ACEI for all pts, anti-HPTN of choice for DM, reserved 4 pts 4 whom diuretics or beta-blockers r unsuccessful, more potent, long T1/2; ADRs: dry cough, rash, fever, altered taste, hypoTN, hyperkalemia, angioedema & 1st dose syncope, not 4 pregnancy |
Na Nitroprusside | MOA: rapid & potent used in the hospital setting for HPTN crisis (150/210), administered IV, vasodilation causes decreased preload; ADRs: metabolized to cyanide thus to prevent use via IV, but can use Na thiosulfate if problemic |
Prazosin | MOA: alpha-blocker cause arteriolar vasodilation, ADRs: reflex tachy & 1st dose syncope |
Terazosin | MOA: alpha-blocker cause arteriolar vasodilation, ADRs: reflex tachy & 1st dose syncope |
Saralasin | MOA: ACEI for all pts, anti-HPTN of choice for DM, reserved 4 pts 4 whom diuretics or beta-blockers r unsuccessful, - angiotensin receptor; ADRs: dry cough, rash, fever, altered taste, hypoTN, hyperkalemia, angioedema & 1st dose syncope, not 4 pregnancy |
Losartan | MOA: Angiotensin 2 antagonists block receptor producing vasodilation and decreased aldosterone, no cough associated because no effects on bradykinin levels |
Candesartan | MOA: Angiotensin 2 antagonists block receptor producing vasodilation and decreased aldosterone, no cough associated because no effects on bradykinin levels |
Valsartan | MOA: Angiotensin 2 antagonists block receptor producing vasodilation and decreased aldosterone, no cough associated because no effects on bradykinin levels |
Clonidine | MOA: central alpha 2 agonist working to depress sympathetic outflow |
Hydralazine | MOA: smooth muscle relaxant producing vasodilation |
Alpha-methyldopa | MOA: central alpha 2 agonist |
Minoxidil | MOA: vasodilator, ADRs: hypertrichosis |
Diazoxide | MOA: direct arteriolar vasodilator, effects similar to hydralazine |
Spironolactone | MOA: aldosterone antagonist, prevents aldosterone mediated effects allow for reduction of blood mmHg, considered a K sparing diuretic; ADRs: hyperkalemia and hormone-related side effects include menstrual irregularities & gyncomastia |